Share
Print
A+
A-

Yicura BioMed Limited

Writer:   |  Editor: Cao Zhen  |  From: HTCZ-SZ  |  Updated: 2026-11-11



Yicura BioMed Limited is a clinical stage biotechnology group, focusing on research and development of innovative DNA medicines and antibody immunotherapies to fight against cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA Vaccine, Anti-Δ42PD1 Antibody; and Vaccine Delivery platforms.